Update: BioNTech Shares Fall as Phase 3 Trial of Combined Influenza, COVID-19 Vaccine With Pfizer Misses 1 of 2 Immunogenicity Targets
Update: BioNTech Shares Fall as Phase 3 Trial of Combined Influenza, COVID-19 Vaccine With Pfizer Misses 1 of 2 Immunogenicity Targets
更新：biontech股价下跌，与辉瑞联合研制的流感和COVID-19组合疫苗III期试验未达到2个免疫原性目标中的1个
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册